Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.01 USD | -1.95% | -10.67% | -24.72% |
14/05 | Cyclacel Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
14/05 | Transcript : Cyclacel Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.72% | 2.94M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-0.61% | 21.83B | |
-10.49% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Earnings Flash (CYCC) CYCLACEL Reports Q2 Loss $-0.46, vs. Street Est of $-0.54